Crescent Sterling’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-37,828
Closed -$2.23M 78
2024
Q2
$2.23M Sell
37,828
-3,233
-8% -$202K 2.14% 15
2024
Q1
$3.28M Sell
41,061
-45
-0.1% -$3.44K 2.98% 10
2023
Q4
$3.25M Sell
41,106
-192
-0.5% -$13.7K 3.24% 10
2023
Q3
$2.88M Sell
41,298
-1,600
-4% -$113K 3.05% 11
2023
Q2
$2.97M Buy
42,898
+1,182
+3% +$84.1K 2.81% 13
2023
Q1
$3.1M Buy
41,716
+2,068
+5% +$173K 3.01% 10
2022
Q4
$3.69M Buy
+39,648
New +$3.83M 3.96% 8

Other funds holding CVS

Crescent Sterling's CVS Position: Q3 2024 in Review

Crescent Sterling sold out of CVS Health (CVS) in Q3 2024, closing a stake of 37,828 shares — an estimated $2.23M sold.

Crescent Sterling first reported a position in CVS in Q4 2022 and held it in 7 quarters. The position peaked at $3.69M in Q4 2022. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

  • Crescent Sterling reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
  • Crescent Sterling sold 37,828 CVS Health shares in Q3 2024, an estimated $2.23M.
  • Crescent Sterling first reported a position in CVS Health in Q4 2022 and held it in 7 quarters.
  • Crescent Sterling's CVS Health position peaked at $3.69M in Q4 2022.
  • 1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Crescent Sterling's 13F filing for Q3 2024, filed 15 Oct 2024.